Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2

被引:90
作者
Subach, BR
Kondziolka, D
Lunsford, LD
Bissonette, DJ
Flickinger, JC
Maitz, AH
机构
[1] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Med Ctr, Dept Radiat Oncol, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Med Ctr, Ctr Image Guided Neurosurg, Pittsburgh, PA 15260 USA
关键词
radiosurgery; acoustic neuroma; neurofibromatosis; vestibular schwannoma;
D O I
10.3171/jns.1999.90.5.0815
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Stereotactically guided radiosurgery is one of the primary treatment modalities for patients with acoustic neuromas (vestibular schwannomas). The goal of radiosurgery is to arrest tumor growth while preserving neurological function. Patients with acoustic neuromas associated with neurofibromatosis Type 2 (NF2) represent a special challenge because of the risk of complete deafness. To define better the tumor control rate and long-term functional outcome, the authors reviewed their 10-year experience in treating these lesions. Methods. Forty patients underwent stereotactic radiosurgery at the University of Pittsburgh, 35 of them for solitary tumors. The other five underwent staged procedures for bilateral lesions (10 tumors: 45 total). Thirteen patients (with 29% of tumors) had undergone a median of two prior resections. The mean tumor volume at radiosurgery was 4.8 mi, and the mean tumor margin dose was 15 Gy (range 12-20 Gy). The overall tumor control rate was 98%. During the median follow-up period of 36 months, 16 tumors (36%) re greased, 28 (62%) remained unchanged, and one (2%) grew. In the 10 patients for whom more than 5 years of clinical and neuroimaging follow-up results were available (median 92 months), five tumors were smaller and five remained unchanged. Surgical resection was performed in three patients (7%) after radiosurgery; only one showed radiographic evidence of progression. Useful hearing (Gardner-Robertson Class I or II) was preserved in six (43%) of 14 patients, and this rate improved to 67% after modifications made in 1992. Normal facial nerve function (House-Brackmann Grade 1) was preserved in 25 (81%) of 31 patients. Normal trigeminal nerve function was preserved in 34 (94%) of 36 patients. Conclusions. Stereotactically guided radiosurgery is a safe and effective treatment for patients with acoustic tumors in the setting of NF2. The rate of hearing preservation may be better with radiosurgery than with other available techniques.
引用
收藏
页码:815 / 822
页数:8
相关论文
共 50 条
[41]   Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience [J].
Sakanaka, Katsuyuki ;
Mizowaki, Takashi ;
Arakawa, Yoshiki ;
Araki, Norio ;
Oya, Natsuo ;
Takahashi, Jun A. ;
Mikuni, Nobuhiro ;
Miyamoto, Susumu ;
Hashimoto, Nobuo ;
Hiraoka, Masahiro .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (01) :27-32
[42]   Management of Neurofibromatosis Type 2 Associated Vestibular Schwannomas [J].
Huan Jia ;
Ghizlene Lahlou ;
Hao Wu ;
Olivier Sterkers ;
Michel Kalamarides .
Current Otorhinolaryngology Reports, 2021, 9 :170-176
[43]   Radiosurgery Treatment of Acoustic Neuromas. Our Experience [J].
de Paula Vernetta, Carlos ;
Orts Alborch, Miguel H. ;
Garcia Callejo, Francisco Javier ;
Ramirez Sabio, Judith Begona ;
Morant Ventura, Antonio ;
Marco Algarra, Jaime .
ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2007, 58 (03) :75-78
[44]   Management strategies in neurofibromatosis type 2 [J].
Moffat, DA ;
Quaranta, N ;
Baguley, DM ;
Hardy, DG ;
Chang, P .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (01) :12-18
[45]   Neurotological complications after radiosurgery versus conservative management in acoustic neuromas: A systematic review-based study [J].
Shin, YJ ;
Lapeyre-Mestre, M ;
Gafsi, I ;
Cognard, C ;
Deguine, O ;
Tremoulet, M ;
Fraysse, B .
ACTA OTO-LARYNGOLOGICA, 2003, 123 (01) :59-64
[46]   Fractionated stereotactic radiotherapy for acoustic neuromas: preservation of function versus size [J].
Williams, JA .
JOURNAL OF CLINICAL NEUROSCIENCE, 2003, 10 (01) :48-52
[47]   NONSURGICAL MANAGEMENT OF ACOUSTIC NEUROMAS [J].
ANAND, VT ;
KERR, AG ;
BYRNES, DP ;
SMYTH, GDL .
CLINICAL OTOLARYNGOLOGY, 1992, 17 (05) :406-410
[48]   Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review [J].
Thien Nguyen ;
Lawrance K. Chung ;
John P. Sheppard ;
Nikhilesh S. Bhatt ;
Cheng Hao Jacky Chen ;
Carlito Lagman ;
Tania Kaprealian ;
Percy Lee ;
Phioanh L. Nghiemphu ;
Isaac Yang .
Neurosurgical Review, 2019, 42 :85-96
[49]   TOWARD DOSE OPTIMIZATION FOR FRACTIONATED STEREOTACTIC RADIOTHERAPY FOR ACOUSTIC NEUROMAS: COMPARISON OF TWO DOSE COHORTS [J].
Andrews, David W. ;
Werner-Wasik, Maria ;
Den, Robert B. ;
Paek, Sun Ha ;
Downes-Phillips, Beverly ;
Willcox, Thomas O. ;
Bednarz, Greg ;
Maltenfort, Mitchell ;
Evans, James J. ;
Curran, Walter J., Jr. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02) :419-426
[50]   Safety and efficacy of fractionated stereotactic radiotherapy for acoustic neuromas [J].
Shearwood McClelland ;
Bruce J. Gerbi ;
Patrick D. Higgins ;
James B. Orner ;
Walter A. Hall .
Journal of Neuro-Oncology, 2008, 86 :191-194